홈 › 비소세포폐암 › 뉴욕

뉴욕의 비소세포폐암 임상 시험

비소세포폐암 관련 연구 169개가 뉴욕 내 여러 지역에서 참여자를 모집하고 있습니다.

뉴욕의 도시

공식 연구 텍스트(영어)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Northwell Health Imbert Cancer Center, Bay Shore
Maimonides Medical Center, Brooklyn
Roswell Park Cancer Institute, Buffalo
외 18개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04267848

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Roswell Park Cancer Institute ( Site 0184), Buffalo
Hematology-Oncology Associates of CNY ( Site 0164), East Syracuse
The Blavatnik Family- Chelsea Medical Center at Mount Sinai ( Site 0216), New York
외 5개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06623422

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

New York Cancer & Blood Specialists - New Hyde Park, New Hyde Park
New York Cancer & Blood Specialists - Cancer Center - Research Headquarters, New York
New York Cancer & Blood Specialists - Patchogue Medical Oncology, Patchogue

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06472245

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
New York Proton Center, New York
외 9개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT07293247

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Columbia University Medical Center, New York
Memorial Sloan Kettering, New York

피험자 모집 중1/2상

12세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT04585750

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
Icahn School of Medicine at Mount Sinai, New York
외 2개

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06465069

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Local Institution - 0080, New York

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT07680764

A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.

NYU Langone Hospital Long Island, Mineola
NYU Langone Hospital Manhattan, New York
Jacobi Medical Center - Albert Einstein College of Medicine, The Bronx
외 1개

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT07365319

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

START New York Long Island LLC, Lake Success

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06270706

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Exelixis Clinical Site #60, New York
Exelixis Clinical Site #6, New York
Exelixis Clinical Site #76, Syracuse

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT05176483

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

New York Oncology Hematology, P.C. ( Site 9000), Albany
White Plains Hospital ( Site 3213), White Plains

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT07513376

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Roswell Park Cancer Institute IDS, Buffalo
Memorial Sloan Kettering Hospital, New York

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06172478

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

Hematology Oncology Associates of CNY at Camillus, Camillus
Hematology Oncology Associates of Central New York-East Syracuse, East Syracuse
Stony Brook University Medical Center, Stony Brook

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT07388524

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Columbia University Irving Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06625775

A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

New York Oncology Hematology P.C ( Site 9000), Albany

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT07554339

A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)

New York Oncology Hematology, P.C. ( Site 0119), Albany
Wilmot Cancer Institute ( Site 0141), Rochester

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT07190248

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Montefiore Medical Center-Einstein Campus, The Bronx
Montefiore Medical Center-Weiler Hospital, The Bronx
Montefiore Medical Center - Moses Campus, The Bronx
외 1개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06498635

A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Memorial Sloan Kettering Cancer Center, New York
Optum Medical Care, PC, Westbury

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07361497

A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)

Local Institution - 0224, Laurelton
Memorial Sloan Kettering Cancer Center, New York
Optum Medical Care, PC, Westbury

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07361510

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer

NYU, New York
Memorial Sloan Kettering Cancer Center, New York

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07659782

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

NYU Langone's Perlmutter Cancer Center, New York
Memorial Sloan Kettering Cancer Center, New York
Optum Medical Care, PC, Westbury

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT06765109

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, New York

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05877599

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

New York Cancer And Blood Specialists - Shirley /ID# 272547, Shirley

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT06772623

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Cancer Center, New York
Montefiore Medical Center, The Bronx

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT06881784

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

Montefiore Medical Center - Montefiore Medical Park, The Bronx
White Plains Hospital, White Plains

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07144280

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Cayuga Medical Center ( Site 0086), Ithaca
University Hospital at Stony Brook ( Site 0054), Stony Brook
White Plains Hospital ( Site 0091), White Plains

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06312137

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

New York Oncology Hematology, Albany
New York Oncology Hematology, Clifton Park
Hematology Oncology Associates of Rockland, Nyack

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07222566

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Research Site, New York
Research Site, New York

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06218914

A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer

New York University Langone Medical Center, New York

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07227025

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

NYU Langone Medical Center, New York

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT04981119

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Hematology Oncology Associates of Rockland, Nyack

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06758401

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Hematology-Oncology Associates of CNY, East Syracuse
Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola
NYU Langone Health Laura and Isaac Perlmutter Cancer Center, New York
외 4개

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06667076